The Ramification of Risk Management on the performance of Pharmaceutical Businesses Operating in Addis Ababa, Ethiopia
No Thumbnail Available
Date
2023-05-25
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
AAU
Abstract
The overriding purpose of the research is to investigate the ramifications of risk management on
the overall business performance of pharmaceutical companies working in Addis Ababa City
Administration. It’s also for filling the literature and knowledge gap seen in the pharmaceutical
business sector risk management practice. Evidently, there’s a dearth of study on risk
management of pharmaceutical sectors in Africa, particularly in Ethiopia and its capital Addis
Ababa; therefore the study prominently enable pharmaceutical businesses working in the city;
categorically pharmaceutical manufacturers/ import & wholesalers/ retail outlets to survive and
sustain businesses, not only that but also to thrive in an increasingly uncertain pharmaceutical
business environment. The research was employed an empirical research design and quantitative
research approach. Both primary and secondary data was employed. Questionnaire was the
main data collection instrument. Among 1567 pharmaceutical firms, 340 sample sizes were
selected using stratified random sampling technique.
Multiple linear regressions were used to analyze the relationships between independent and
dependent variables. Statistical package for social science (SPSS) version 29 was used to
analysis of quantitative data from the questionnaire. Moreover, the research finding shows that
the independent variables risk identification, risk assessment, risk response and risk monitoring
significantly affects the business performance of companies in the pharmaceutical sector.
Based on the findings pharmaceutical companies in Addis Ababa face a two-fold challenge with
respect to overall business risk. First, they need to identify and understand the specific risks they
face, and, second, they must also create a fundamental, practical approach for evaluating these
risks. Particularly for large pharmaceutical companies in the city who adopts well founded
organizational structure and leadership system, implementing strategies to address anything that
could go wrong in the businesses they run is monumental.
xiv
Furthermore, as the pharmaceutical business sector grow, evolves and changes in the city, so
too will the natures of the risks these companies face. The risks and there management
recommendations here are those that the research output vindicate and/or believe should be at
the forefront of pharmaceutical leader’s minds. A risk intelligent approach to comprehending
and addressing risks can help keep pharmaceutical companies attuned to what risks are most
important, what risks may be emerging, and what can be done to both manage risks and
capitalize on them